Cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau, and quantification of cortical amyloid burden by positron emission tomography (PET) remain among the best‐established biomarkers of Alzheimer's disease (AD). The gene discussed is MAPT; the disease is Alzheimer disease.